UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Boosted by Intact Investment Management Inc.

Intact Investment Management Inc. boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 120.0% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,200 shares of the healthcare conglomerate's stock after buying an additional 1,200 shares during the period. Intact Investment Management Inc.'s holdings in UnitedHealth Group were worth $1,152,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of UNH. NewSquare Capital LLC bought a new position in UnitedHealth Group in the 4th quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the 4th quarter valued at about $26,000. Hurley Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $28,000. Aster Capital Management DIFC Ltd acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $30,000. Finally, Promus Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $32,000. Institutional investors own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. Piper Sandler cut their price target on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a report on Tuesday, June 3rd. TD Cowen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target for the company. in a report on Monday, May 19th. Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. Oppenheimer reduced their price objective on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research note on Wednesday, May 14th. Finally, JPMorgan Chase & Co. upped their price objective on shares of UnitedHealth Group from $405.00 to $418.00 and gave the company an "overweight" rating in a research note on Friday. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, UnitedHealth Group currently has an average rating of "Moderate Buy" and a consensus price target of $427.09.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares of the company's stock, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Kristen Gil bought 3,700 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, May 15th. The stock was purchased at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the transaction, the director now owns 3,818 shares of the company's stock, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased a total of 109,408 shares of company stock worth $31,607,768 over the last 90 days. Insiders own 0.28% of the company's stock.

UnitedHealth Group Trading Down 1.7%

NYSE:UNH opened at $302.04 on Monday. The stock's 50 day moving average price is $359.15 and its 200 day moving average price is $461.96. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The company has a market capitalization of $273.99 billion, a P/E ratio of 12.65, a P/E/G ratio of 1.42 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the business earned $6.91 EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.93%. The ex-dividend date of this dividend is Monday, June 16th. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.